Genetic Carrier Screening
"Genetic Carrier Screening" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Identification of individuals who are heterozygous at a GENETIC LOCUS for a recessive PHENOTYPE.
Descriptor ID |
D006580
|
MeSH Number(s) |
E01.370.225.562.250 E05.200.562.250 E05.393.435.250 N02.421.308.200 N02.421.726.233.221.250
|
Concept/Terms |
Genetic Carrier Screening- Genetic Carrier Screening
- Carrier Screening, Genetic
- Screening, Genetic Carrier
- Screenings, Genetic Carrier
- Carrier Detection, Genetic
- Heterozygote Detection
- Detection, Heterozygote
- Genetic Carrier Detection
- Carriers, Genetic, Detection
- Genetic Carriers, Detection
- Heterozygote Screening
- Screening, Heterozygote
- Detection, Genetic Carrier
|
Below are MeSH descriptors whose meaning is more general than "Genetic Carrier Screening".
Below are MeSH descriptors whose meaning is more specific than "Genetic Carrier Screening".
This graph shows the total number of publications written about "Genetic Carrier Screening" by people in this website by year, and whether "Genetic Carrier Screening" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 0 | 1 | 1 |
1996 | 0 | 3 | 3 |
1998 | 0 | 2 | 2 |
2000 | 0 | 2 | 2 |
2001 | 1 | 0 | 1 |
2002 | 1 | 1 | 2 |
2003 | 0 | 2 | 2 |
2004 | 0 | 2 | 2 |
2006 | 3 | 2 | 5 |
2007 | 0 | 3 | 3 |
2008 | 1 | 2 | 3 |
2009 | 1 | 1 | 2 |
2010 | 0 | 1 | 1 |
2011 | 3 | 1 | 4 |
2014 | 0 | 1 | 1 |
2016 | 1 | 0 | 1 |
2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Genetic Carrier Screening" by people in Profiles.
-
Disparities among infertility patients regarding genetic carrier screening, sex selection, and gene editing. J Assist Reprod Genet. 2021 Sep; 38(9):2319-2325.
-
A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer. Prostate. 2018 06; 78(8):607-615.
-
Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. PLoS One. 2016; 11(7):e0158801.
-
Disclosure of genetic research results to members of a founder population. J Genet Couns. 2014 Dec; 23(6):984-91.
-
A re-examination of the use of ethnicity in prenatal carrier testing. Am J Med Genet A. 2012 Jan; 158A(1):19-23.
-
Ethical and policy issues raised by heterozygote carrier identification and predictive genetic testing of adolescents. Adolesc Med State Art Rev. 2011 Aug; 22(2):251-64, ix.
-
A common spinal muscular atrophy deletion mutation is present on a single founder haplotype in the US Hutterites. Eur J Hum Genet. 2011 Oct; 19(10):1045-51.
-
Parental understanding of newborn screening for cystic fibrosis after a negative sweat-test. Pediatrics. 2011 Feb; 127(2):276-83.
-
A pilot study to evaluate knowledge and attitudes of Illinois pediatricians toward newborn screening for sickle cell disease and cystic fibrosis. Am J Perinatol. 2011 Mar; 28(3):169-76.
-
PGD for all cystic fibrosis carrier couples: novel strategy for preventive medicine and cost analysis. Reprod Biomed Online. 2010 Aug; 21(2):186-95.